Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) EPS (Weighted Average and Diluted) (2021 - 2025)

Bio Essence has reported EPS (Weighted Average and Diluted) over the past 5 years, most recently at $0.02 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at $0.02 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $0.01 (up 125.0% YoY), and the annual figure for FY2025 was $0.02, up 166.67%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.02 at Bio Essence, up from -$0.01 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for BIOE hit a ceiling of $0.02 in Q4 2025 and a floor of -$0.03 in Q3 2024.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.0 (2021), compared with a mean of -$0.0.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 301.04% in 2023 and later skyrocketed 199.38% in 2024.
  • Bio Essence's EPS (Weighted Average and Diluted) stood at $0.0 in 2021, then skyrocketed by 135.16% to $0.01 in 2022, then crashed by 254.88% to -$0.01 in 2023, then tumbled by 200.0% to -$0.03 in 2024, then skyrocketed by 166.67% to $0.02 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.02 (Q4 2025), -$0.01 (Q1 2025), and -$0.03 (Q3 2024) per Business Quant data.